Search research articles
Contact Us
Filters
Showing results (121-130 of 127) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 127 results.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Blood Advances
|
May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL
Anthony R Mato, Lindsey E Roeker, Toby A Eyre, et al.
Leukemia
|
May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Blood
|
March 17, 2026
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study
Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia, et al.
Blood
|
January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
Matthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Haematologica
|
May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing
Wendy Osborne, Euan Haynes, William Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Anthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 127) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 127 results.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Blood Advances
|
May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL
Anthony R Mato, Lindsey E Roeker, Toby A Eyre, et al.
Leukemia
|
May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Blood
|
March 17, 2026
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study
Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia, et al.
Blood
|
January 7, 2022
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
Matthew R Wilson, Toby A Eyre, Amy A Kirkwood, et al.
Haematologica
|
May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing
Wendy Osborne, Euan Haynes, William Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Anthony R Mato, Lindsey E Roeker, Ryan Jacobs, et al.
Page
of 13